z-logo
open-access-imgOpen Access
CORTICOBASAL SYNDROME: A PROSPECTIVE STUDY OF CLINICAL PROFILES AND IMAGING BIOMARKERS
Author(s) -
Jacy Bezerra Parmera,
Artur Martins Coutinho,
Isabel Almeida,
Camila de Godoi Carneiro,
Carla Rachel Ono,
Adalberto Studart Neto,
Egberto Reis Barbosa,
Carlos Alberto Buchpiguel,
Ricardo Nitríni,
Sonia Brucki
Publication year - 2021
Publication title -
dementia and neuropsychologia
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 0.54
H-Index - 21
ISSN - 1980-5764
DOI - 10.5327/1980-5764.rpda010
Subject(s) - pittsburgh compound b , corticobasal degeneration , positron emission tomography , medicine , nuclear medicine , progressive supranuclear palsy , psychology , globus pallidus , cognitive impairment , pathology , disease , basal ganglia , central nervous system
Background: Corticobasal syndrome (CBS) is neurodegenerative disorder related to multiple underlying pathologies. Objective: To investigated if dividual FDG-PET patterns could distinguish CBS due to Alzheimer’s disease (AD) from other pathologies based on [11C]Pittsburgh Compound-B (PIB)-PET. Methods: Forty-five patients with probable CBS were prospectively evaluated. They underwent FDG-PET and were divided into groups: related to AD (CBS FDG-AD) or non-AD (CBS FDG-nonAD). Thirty patients underwent PIB-PET on a PET-MRI to assess their amyloid status. FDG and PIB-PET were classified individually on visual analysis, and PET-MRI quantitative group analyses were performed. Results: CBS FDG-AD group (33.3%) showed worse cognitive performances, displayed more myoclonus and hallucinations. CBS FDG-nonAD group (66.7%) presented more dystonia, ocular motor dysfunction, perseveration, and dysarthria. All CBS FDG-AD patients tested positive at PIB-PET compared to 3 out of 20 in the non-AD group. The individual FDG-PET classification had 76.92% of sensitivity, 100% of specificity and 88.5% of accuracy to detect positive PIB-PET scans. Individuals with positive and negative PIB-PET showed hypometabolism in temporoparietal areas and in thalamus and brainstem, respectively, disclosing metabolic signatures. Conclusion: CBS is mainly distinguished by two variants (AD and non-AD), with different cognitive profiles and possibly motor features. FDG-PET was useful depicting their specific degeneration patterns and brain amyloid deposition.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here